Trump said he doesn't see a recession after the bond market spooked investors and the Dow suffered its worst day of the year last week.Marketsread more
Ahead of the deadline, U.S. President Donald Trump told reporters that Huawei was a national security threat.Technologyread more
Americans now say they approve of free trade by 64%-27%, a margin of better than two to one. That's up from 57%-37% early in Trump's presidency, and 51%-41% near the end of...Politicsread more
Stocks in Asia edged up Monday afternoon as U.S. Treasury yields bounced higher after plunging last week.Asia Marketsread more
The problem with tanking equities lies elsewhere, writes Michael Ivanovitch, because traders see no end to America's unfolding trade disputes with Europe and China.World Economyread more
Beijing wants to use reforms to support a slowing economy.China Marketsread more
Trump said Cook made a "good case" that it would be difficult for Apple to pay tariffs, when Samsung does not face the same hurdle because much of its manufacturing is in...Technologyread more
The yield on the benchmark 10-year Treasury note briefly fell below the 2-year rate on Wednesday, a phenomenon in the bond market known as yield curve inversion, which is...Marketsread more
Despite aggressive strides, Waymo needs one thing before their self-driving cars become a seriously useful transportation system: people. We talked to the ones closest to it.Technologyread more
The hearing will now begin next Monday to allow time for the completion of a previous trial that revolves around former 1MDB unit SRC International, a Kuala Lumpur High Court...Asia Newsread more
"I don't want to do business at all because it is a national security threat," Trump told reporters.Technologyread more
One of the most valuable Silicon Valley startups is under fire.
Theranos, the medical technology firm founded by Elizabeth Holmes, may have exaggerated the success of lab tests conducted on its own machines, The Wall Street Journal reported Thursday, citing several former employees.
The Journal was also told by the former employees that some company workers were skeptical about the accuracy of Theranos' in-house marquee testing machine, the Edison.
David Boies, the company's outside lawyer, told the WSJ that Theranos is not using the device for all its test, saying the transition is "a journey."
One worker even said in a complaint to regulators that the company failed to report test results that raised concerns about how precise the Edison system is.
Boies and Heather King, Theranos' general counsel, both denied claims that the tests are inaccurate to the Journal. King added the company has been "upfront and transparent with regulators" about its procedures.
Theranos later said in a statement: "Today's Wall Street Journal story about Theranos is factually and scientifically erroneous and grounded in baseless assertions by inexperienced and disgruntled former employees and industry incumbents. Theranos presented the facts to this reporter to prove the accuracy and reliability of its tests and to directly refute these false allegations, including more than 1,000 pages of statements and documents. "
"Disappointingly, the Journal chose to publish this article without even mentioning the facts Theranos shared that disproved the many falsehoods in the article, " the company added.
A WSJ spokesperson later told CNBC the newspaper "fully stands by [author]John Carreyrou's article about Theranos, which was richly sourced and thoroughly researched."
Boies did not immediately respond to CNBC's requests for comment.
Theranos was founded in 2003 after Holmes dropped out of Stanford University and is valued at $9 billion.
Click here to read the full report.
Programming note: Elizabeth Holmes will be on CNBC's "Mad Money" tonight at 6 p.m. ET.